This inventor holds 7 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1981-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-2003
Title: Merlyn G Flom: Innovator in Pharmaceutical Science
Introduction
Merlyn G Flom is a notable inventor based in Noblesville, IN (US), recognized for his contributions to pharmaceutical science. He holds a total of 7 patents, showcasing his innovative spirit and dedication to advancing medical research.
Latest Patents
Flom's latest patents include a novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride. This invention is directed towards a crystalline hydrate that has significant implications for treating various disease states associated with estrogen deprivation. These conditions include cardiovascular disease, hyperlipidemia, osteoporosis, and other pathological issues such as endometriosis, uterine fibrosis, and several types of cancer. The patent also addresses the prevention of breast cancer and the up-regulation of ChAT, highlighting its potential impact on CNS disorders, including Alzheimer's disease.
Career Highlights
Flom is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to focus on developing groundbreaking treatments that address critical health issues.
Collaborations
Throughout his career, Flom has collaborated with esteemed colleagues, including Anne M Herrold and Joe O Martin. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Merlyn G Flom's contributions to pharmaceutical science through his innovative patents and collaborations underscore his importance in the field. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
